Last reviewed · How we verify

NCT07127575

Scalable Intervention for Stress Management

Recruiting now NA Last updated 17 August 2025
What this trial tests

NA trial testing Resistance Breathing Device in Stress in 60 participants. Currently enrolling.

Timeline
1 August 2025
Primary endpoint
30 September 2025
30 September 2025

Quick facts

Lead sponsorLivotion, LLC
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 August 2025
Primary completion30 September 2025
Estimated completion30 September 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Livotion, LLC

Who can join

Adults 18 to 30, any sex, with Stress or Diaphragmatic Breathing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other Livotion, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07127575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing